BioSpace News Archive

Description: The research report on ‘Global molecular biology enzymes, reagents and kits market’ meticulously studies this industry vertical, highlighting the predominant trends, growth driving factors, challenges, and opportunities that will shape the business dynamics during 2020-2027.

- Vuzix delivers remote servicing solutions to the medical device market to assist in compliance with COVID-19 travel and site visit restrictions

Worldwide Exclusive License Provides Access to Targeted Digital Sequencing (TARDIS) Blood Biopsy Method for Use in Minimal Residual Disease Testing

TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) (“Tonix” or the “Company”), a clinical-stage biopharmaceutical company, today announced the closing of its previously announced registered direct offering, priced at-the-market, with gross proceeds of $40.0 million before deducting fees and other estimated offering expenses.

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today reported preliminary revenue results for the full year and fourth quarter ended December 31, 2020.

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immune-mediated diseases, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. Aldeyra also expects to grant the underwriters a

Aligns legal charter with company’s long-term view and commitment to all stakeholders, including customers, employees, and shareholders Proposal passes by landslide as Veeva garners widespread support for leading in stakeholder capitalism

The Muscular Dystrophy Association announced it has appointed Kristine Welker to the newly created role of chief of staff.

New platform from biotech community leader to coordinate, support and connect STEM and workforce education non-profits with biotech startups, investors and sponsors for larger impact

ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ), has recently been issued United States Patent 10888898 (898 patent) entitled Ultrasound Transducer and Imaging System Employing the Same from the United States Patent and Trademark Office.